Claude Runs Its Own Protein Design Campaigns, Beats the Drug Discovery Industry Norm

Today we're covering the biggest AI stories of August 20th, 2026. Anthropic published research showing its Mythos Preview and Opus 4.8 models ran protein design campaigns largely on their own, a key early step in drug discovery, hitting working molecules on 14 out of 15 targets with 22 to 35 percent success rates on molecules that actually gripped their target, well above the typical 10 to 15 percent industry norm, using just one expert written prompt plus internet access and tools, with outside labs Twist Bioscience and Adaptyv Bio handling the physical lab work and measurements. In a separate test, Opus 5 opened raw instrument files with no lab software and measured a sample at 96.4 percent purity in 19 minutes, a task that took the lab's own team four days, landing just days after Dario Amodei predicted "early glimmers" in biology were still months away. Plus, Replit launched Free Mode, running everyday chats on OpenAI's discounted Luna model without burning user credits, giving its $20 plan up to 30 times more usage, and today's community workflow comes from Matthew, who built a reusable weekly safety course generator for his son by having Claude document a swim safety lesson as a standing template he now refills with a new topic every week through Cowork.